kainate receptor antagonists (Abbott)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namekainate receptor antagonists (Abbott)
Drug Alias NameBSF-111886BSF-84077BSF-91594
ClassificationSmall molecules
Mechanisms of ActionGlutamate receptor ionotropic kainate antagonistsMetabotropic glutamate receptor 5 antagonistsNeuroprotectants
TargetsGlutamate receptor ionotropic kainateMetabotropic glutamate receptor 5
Therapy Area/IndicationsCraniocerebral TraumaEpilepsyStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Deutschland Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Deutschland Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsCraniocerebral TraumaEpilepsyStroke

Other Information

ATC CodeN/A
Related LinksN/A